Ethylmalonic encephalopathy ETHE1 R163W/R163Q mutations alter protein stability and redox properties of the iron centre
- PMID: 25198162
- PMCID: PMC4157841
- DOI: 10.1371/journal.pone.0107157
Ethylmalonic encephalopathy ETHE1 R163W/R163Q mutations alter protein stability and redox properties of the iron centre
Abstract
ETHE1 is an iron-containing protein from the metallo β-lactamase family involved in the mitochondrial sulfide oxidation pathway. Mutations in ETHE1 causing loss of function result in sulfide toxicity and in the rare fatal disease Ethylmalonic Encephalopathy (EE). Frequently mutations resulting in depletion of ETHE1 in patient cells are due to severe structural and folding defects. However, some ETHE1 mutations yield nearly normal protein levels and in these cases disease mechanism was suspected to lie in compromised catalytic activity. To address this issue and to elicit how ETHE1 dysfunction results in EE, we have investigated two such pathological mutations, ETHE1-p.Arg163Gln and p.Arg163Trp. In addition, we report a number of benchmark properties of wild type human ETHE1, including for the first time the redox properties of the mononuclear iron centre. We show that loss of function in these variants results from a combination of decreased protein stability and activity. Although structural assessment revealed that the protein fold is not perturbed by mutations, both variants have decreased thermal stabilities and higher proteolytic susceptibilities. ETHE1 wild type and variants bind 1 ± 0.2 mol iron/protein and no zinc; however, the variants exhibited only ≈ 10% of wild-type catalytically activity. Analysis of the redox properties of ETHE1 mononuclear iron centre revealed that the variants have lowered reduction potentials with respect to that of the wild type. This illustrates how point mutation-induced loss of function may arise via very discrete subtle conformational effects on the protein fold and active site chemistry, without extensive disruption of the protein structure or protein-cofactor association.
Conflict of interest statement
Figures


Similar articles
-
Crystal structure of human persulfide dioxygenase: structural basis of ethylmalonic encephalopathy.Hum Mol Genet. 2015 May 1;24(9):2458-69. doi: 10.1093/hmg/ddv007. Epub 2015 Jan 16. Hum Mol Genet. 2015. PMID: 25596185 Free PMC article.
-
Characterization of patient mutations in human persulfide dioxygenase (ETHE1) involved in H2S catabolism.J Biol Chem. 2012 Dec 28;287(53):44561-7. doi: 10.1074/jbc.M112.407411. Epub 2012 Nov 9. J Biol Chem. 2012. PMID: 23144459 Free PMC article.
-
An atypically mild case of ethylmalonic encephalopathy with pathogenic ETHE1 variant.Am J Med Genet A. 2023 Jun;191(6):1614-1618. doi: 10.1002/ajmg.a.63176. Epub 2023 Mar 9. Am J Med Genet A. 2023. PMID: 36891747
-
Mitochondrial Dysfunction and Redox Homeostasis Impairment as Pathomechanisms of Brain Damage in Ethylmalonic Encephalopathy: Insights from Animal and Human Studies.Cell Mol Neurobiol. 2022 Apr;42(3):565-575. doi: 10.1007/s10571-020-00976-2. Epub 2020 Oct 9. Cell Mol Neurobiol. 2022. PMID: 33034777 Free PMC article. Review.
-
Identification of a novel homozygous nonsense variant in a Chinese patient with ethylmalonic encephalopathy and a genotype-phenotype spectrum review.Clin Chim Acta. 2020 Oct;509:8-17. doi: 10.1016/j.cca.2020.05.051. Epub 2020 May 30. Clin Chim Acta. 2020. PMID: 32485156 Review.
Cited by
-
Case Series of Ethylmalonic Encephalopathy from Southern India.J Pediatr Genet. 2021 Dec 6;12(3):213-218. doi: 10.1055/s-0041-1740370. eCollection 2023 Sep. J Pediatr Genet. 2021. PMID: 37575639 Free PMC article.
-
ETHE1 overexpression promotes SIRT1 and PGC1α mediated aerobic glycolysis, oxidative phosphorylation, mitochondrial biogenesis and colorectal cancer.Oncotarget. 2019 Jun 18;10(40):4004-4017. doi: 10.18632/oncotarget.26958. eCollection 2019 Jun 18. Oncotarget. 2019. PMID: 31258845 Free PMC article.
-
Mitochondrial Unfolded Protein Response (mtUPR) Activation Improves Pathological Alterations in Cellular Models of Ethylmalonic Encephalopathy.Antioxidants (Basel). 2025 Jun 16;14(6):741. doi: 10.3390/antiox14060741. Antioxidants (Basel). 2025. PMID: 40563372 Free PMC article.
-
The role of exome sequencing in newborn screening for inborn errors of metabolism.Nat Med. 2020 Sep;26(9):1392-1397. doi: 10.1038/s41591-020-0966-5. Epub 2020 Aug 10. Nat Med. 2020. PMID: 32778825 Free PMC article.
-
Crystal structure of human persulfide dioxygenase: structural basis of ethylmalonic encephalopathy.Hum Mol Genet. 2015 May 1;24(9):2458-69. doi: 10.1093/hmg/ddv007. Epub 2015 Jan 16. Hum Mol Genet. 2015. PMID: 25596185 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical